TD-1473 for Active Ulcerative Colitis (UC)

NCT02818686 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis, Active Moderate
Ulcerative Colitis, Active Severe

Interventions

DRUG: TD-1473
DRUG: Placebo

Sponsor

Theravance Biopharma